Fukoku Mutual Life Insurance’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-400
Closed -$29K 318
2022
Q1
$29K Buy
400
+100
+33% +$8.92K ﹤0.01% 312
2021
Q4
$43K Buy
300
+20
+7% +$3.44K ﹤0.01% 313
2021
Q3
$58K Buy
280
+80
+40% +$17.6K ﹤0.01% 323
2021
Q2
$42K Buy
+200
New +$36.6K ﹤0.01% 323

Other funds holding NVAX

Fukoku Mutual Life Insurance's NVAX Position: Q2 2022 in Review

Fukoku Mutual Life Insurance sold out of Novavax (NVAX) in Q2 2022, closing a stake of 400 shares — an estimated $29K sold.

Fukoku Mutual Life Insurance first reported a position in NVAX in Q2 2021 and held it in 4 quarters. The position peaked at $58K in Q3 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Fukoku Mutual Life Insurance reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Fukoku Mutual Life Insurance sold 400 Novavax shares in Q2 2022, an estimated $29K.
  • Fukoku Mutual Life Insurance first reported a position in Novavax in Q2 2021 and held it in 4 quarters.
  • Fukoku Mutual Life Insurance's Novavax position peaked at $58K in Q3 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Fukoku Mutual Life Insurance's 13F filing for Q2 2022, filed 29 Jul 2022.